VivePeptides logo

Research Use Only

Longevity Peptides

Peptides studied in the context of mitochondrial health, NAD+ pathways, and cellular-aging models.

Longevity Peptides are research compounds studied for their roles in cellular energy metabolism, mitochondrial membrane dynamics, and stress-response signaling pathways investigated in preclinical aging models. The category represented on this page includes NAD+ (a metabolic coenzyme), MOTS-c (a mitochondria-derived signaling peptide), and SS-31 (a mitochondria-targeting tetrapeptide), each supplied by VivePeptides for laboratory research use only.

Reviewed by the VivePeptides Research DeskLast reviewed

Research Catalog

Compounds in this collection

NAD+ research peptide vial

NAD+

$80.00View
MOTS-c research peptide vial

MOTS-c

$75.00View
SS-31 research peptide vial

SS-31

$85.00View

Research Overview

Longevity Peptides in Preclinical Research: Category Overview

The longevity peptides research category encompasses compounds that modulate mitochondrial function, cellular energy status, and stress-resilience pathways studied in aging and metabolic models. This area has drawn sustained scientific attention because mitochondrial dysfunction and declining NAD+ bioavailability are recurring themes in preclinical aging literature, making compounds that intersect these pathways valuable investigative tools. Three distinct mechanism classes are represented in this collection.

NAD+ is a pyridine nucleotide coenzyme central to oxidative phosphorylation and sirtuin-dependent signaling, widely investigated in models of metabolic and cellular aging. MOTS-c is a mitochondria-derived peptide encoded within the 12S rRNA of mitochondrial DNA, studied for its role in metabolic regulation and mitochondrial stress responses. SS-31 (elamipretide) is a synthetic tetrapeptide that selectively targets the inner mitochondrial membrane, examined in preclinical models of mitochondrial membrane integrity and bioenergetic function.

VivePeptides supplies each compound with rigorous purity documentation to support reproducible research.

Three Non-Overlapping Mechanism Classes

NAD+, MOTS-c, and SS-31 each engage mitochondrial biology from a distinct mechanistic entry point, allowing researchers to isolate and interrogate specific nodes of cellular energy metabolism and stress-response signaling independently.

Purity Documentation for Reproducible Studies

Each compound in this collection is supplied with certificate of analysis data confirming identity, purity, and batch-specific characteristics, supporting the documentation standards that preclinical longevity research requires.

Matching Compound to Research Objective

Investigators typically select between these peptides for longevity research based on whether the study targets coenzyme bioavailability, mitochondria-derived peptide signaling, or direct inner membrane stabilization, as each mechanism addresses a distinct and non-redundant biological question.

Compound Comparison

How these compounds compare

CompoundMechanism ClassResearch FocusDistinguishing Feature
NAD+Pyridine nucleotide coenzymeSirtuin activation, metabolic fluxDual nuclear and mitochondrial signaling via coenzyme replenishment
MOTS-cMitochondria-derived signaling peptideAMPK pathway, metabolic stress responseEncoded within mitochondrial 12S rRNA, not nuclear genome
SS-31Mitochondria-targeting synthetic tetrapeptideMembrane integrity, bioenergetic stabilizationSelective cardiolipin binding on inner mitochondrial membrane

Mechanism & Research Context

Mechanism Classes and Research Design Considerations for Anti Aging Peptides

What distinguishes this collection is the diversity of mechanistic entry points into longevity-relevant biology: coenzyme replenishment, mitochondria-derived peptide signaling, and direct mitochondrial membrane targeting represent three non-overlapping research angles. Preclinical literature has examined NAD+ in the context of sirtuin activation, PARP competition, and metabolic flux assays, with studies frequently using aged cell lines or tissues with documented NAD+ depletion to model physiologically relevant conditions.

MOTS-c research has focused on AMPK pathway engagement and nuclear translocation under stress, with investigators noting that its effects in metabolic models differ substantially from those of nuclear-encoded mitochondrial peptides. SS-31 studies have concentrated on cardiolipin interaction and electron transport chain stabilization, with experimental designs often assessing mitochondrial membrane potential and ROS production as primary endpoints.

Researchers selecting between these compounds typically base the choice on which node of mitochondrial biology is under investigation. Each compound presents distinct handling and reconstitution considerations that should be reviewed before study design is finalized.

Research FAQ

Frequently asked questions

What are longevity peptides in the context of laboratory research?

Longevity peptides are research compounds investigated for their roles in mitochondrial function, cellular energy metabolism, and stress-response pathways studied in preclinical aging models. In laboratory settings, they are used to examine mechanisms such as NAD+-dependent sirtuin signaling, mitochondria-derived peptide activity via MOTS-c, and inner membrane stabilization via SS-31. All compounds in this category are supplied for laboratory research use only and are not intended for human or animal administration.

What is the difference between NAD+, MOTS-c, and SS-31 in longevity research?

NAD+, MOTS-c, and SS-31 represent three mechanistically distinct compounds used in longevity-relevant preclinical research, each targeting a different node of mitochondrial biology. NAD+ is a coenzyme studied for sirtuin activation and metabolic flux, MOTS-c is a mitochondria-derived peptide investigated for AMPK engagement and stress signaling, and SS-31 is a synthetic tetrapeptide examined for selective interaction with the inner mitochondrial membrane via cardiolipin binding. Researchers select between them based on which specific aspect of cellular aging or mitochondrial function the study is designed to interrogate.

Are the peptides for longevity on this page approved for human use?

The compounds featured on this page are supplied strictly for laboratory research use only and are not approved for, or intended for, human or animal therapeutic application. NAD+, MOTS-c, and SS-31 remain subjects of ongoing preclinical investigation, and any research use must comply with applicable institutional, ethical, and regulatory guidelines. No health claims are made or implied for any compound on this page.

How do researchers typically design studies using SS-31 in preclinical aging models?

SS-31 preclinical study designs typically use mitochondrial membrane potential and reactive oxygen species production as primary endpoints, reflecting the compound's investigated mechanism of cardiolipin interaction and electron transport chain stabilization. Experimental protocols frequently include mitochondrial isolation procedures and appropriate vehicle controls to isolate membrane-specific effects from broader cellular responses. Investigators should consult current preclinical literature and institutional biosafety guidelines before initiating any in vitro or in vivo study.

What makes MOTS-c a mechanistically distinct compound in the longevity peptides category?

MOTS-c is distinguished from other compounds in this research category by its genomic origin: it is encoded within the 12S rRNA region of mitochondrial DNA, classifying it as a mitochondria-derived peptide rather than a nuclear-encoded or wholly synthetic molecule. Preclinical literature has investigated its capacity for AMPK pathway activation and stress-induced nuclear translocation, behaviors that differ substantially from those of nuclear-encoded mitochondrial proteins. This unique origin and signaling profile makes MOTS-c a mechanistically discrete tool for researchers studying mitochondrial-to-nuclear communication in aging models.

What purity and documentation standards should researchers expect when sourcing anti aging peptides?

Researchers sourcing anti aging peptides for preclinical studies should expect each compound to be accompanied by a certificate of analysis confirming purity, molecular identity, and batch-specific analytical data sufficient to support reproducible experimental outcomes. VivePeptides provides this documentation for NAD+, MOTS-c, and SS-31 in line with research-grade standards expected in peer-reviewed laboratory settings. Reviewing certificate of analysis data before study initiation is a standard practice for verifying compound integrity and ensuring experimental validity.

Related Research Collections

Continue exploring

Peptides for EnergyPeptides for Weight LossGLP-1 PeptidesPeptides for Fat Burning

All products are sold strictly for laboratory and scientific research use only. Not for human or animal consumption, diagnostic, or therapeutic use. Nothing on this page constitutes medical advice or a health claim.